Cargando…
Optimal group testing with heterogeneous risks
We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probab...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243685/ https://www.ncbi.nlm.nih.gov/pubmed/37360771 http://dx.doi.org/10.1007/s00199-023-01502-3 |
_version_ | 1785054477898743808 |
---|---|
author | Bobkova, Nina Chen, Ying Eraslan, Hülya |
author_facet | Bobkova, Nina Chen, Ying Eraslan, Hülya |
author_sort | Bobkova, Nina |
collection | PubMed |
description | We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probabilities, it is optimal to form heterogeneous groups with exactly one high-risk sample per group. Otherwise, it is not optimal to form heterogeneous groups, but homogeneous group testing may still be optimal. For a range of parameters including the U.S. Covid-19 positivity rate for many weeks during the pandemic, the optimal size of a group test is four. We discuss the implications of our results for team design and task assignment. |
format | Online Article Text |
id | pubmed-10243685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-102436852023-06-07 Optimal group testing with heterogeneous risks Bobkova, Nina Chen, Ying Eraslan, Hülya Econ Theory Research Article We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probabilities, it is optimal to form heterogeneous groups with exactly one high-risk sample per group. Otherwise, it is not optimal to form heterogeneous groups, but homogeneous group testing may still be optimal. For a range of parameters including the U.S. Covid-19 positivity rate for many weeks during the pandemic, the optimal size of a group test is four. We discuss the implications of our results for team design and task assignment. Springer Berlin Heidelberg 2023-06-06 /pmc/articles/PMC10243685/ /pubmed/37360771 http://dx.doi.org/10.1007/s00199-023-01502-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Article Bobkova, Nina Chen, Ying Eraslan, Hülya Optimal group testing with heterogeneous risks |
title | Optimal group testing with heterogeneous risks |
title_full | Optimal group testing with heterogeneous risks |
title_fullStr | Optimal group testing with heterogeneous risks |
title_full_unstemmed | Optimal group testing with heterogeneous risks |
title_short | Optimal group testing with heterogeneous risks |
title_sort | optimal group testing with heterogeneous risks |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243685/ https://www.ncbi.nlm.nih.gov/pubmed/37360771 http://dx.doi.org/10.1007/s00199-023-01502-3 |
work_keys_str_mv | AT bobkovanina optimalgrouptestingwithheterogeneousrisks AT chenying optimalgrouptestingwithheterogeneousrisks AT eraslanhulya optimalgrouptestingwithheterogeneousrisks |